Pharmacological Studies of Syrian Rue (Peganum harmala L., Zygophyllaceae)

Öz

Syrian rue (Peganum harmala L., Zygophyllaceae) has been used in traditional medicine of Central Asia, the Middle East, and Caucasus areas (Azerbaijan) for centuries, mainly as ritual and psychedelic plant. At full growth, this erect, dichotomously branched shrub is about 1 m in height with a dense foliage consisting of narrow, linear, pinnate leaves with acute spreading lobes, and small solitary, axillary, white flowers and globe capsules enclosing numerous angular seeds. All parts of the plant (including roots) contain alkaloids. The seeds contain β-carbolineses (harmine, harmalol and harman) with the active hallucinogen being the alkaloid harmine. The seeds contain a red pigment used for coloring wool and carpets and for use as a spice and, in traditional medicine, as valuable aphrodisiac.

Anahtar Kelimeler

• Pharmacological studies
• Syrian rue
• Peganum harmala L.
• Zygophyllaceae

Pharmacological Studies of Syrian Rue (Peganum harmala L., Zygophyllaceae)

Abstract

Syrian rue (Peganum harmala L., Zygophyllaceae) has been used in traditional medicine of Central Asia, the Middle East, and Caucasus areas (Azerbaijan) for centuries, mainly as ritual and psychedelic plant.  At full growth, this erect, dichotomously branched shrub is about 1 m in height with a dense foliage consisting of narrow, linear, pinnate leaves with acute spreading lobes, and small solitary, axillary, white flowers and globe capsules enclosing numerous angular seeds.  All parts of the plant (including roots) contain alkaloids.  The seeds contain β-carbolineses (harmine, harmalol and harman) with the active hallucinogen being the alkaloid harmine.  The seeds contain a red pigment used for coloring wool and carpets and for use as a spice and, in traditional medicine, as valuable aphrodisiac.

Keywords

• pharmacological studies
• Syrian rue
• Peganum harmala L.
• Zygophyllaceae

References

1. Shultes, E. (1976). Hallucinogenic plants, Golden Press, New York
2. Damirov, I.A., Prilipko L.I., Shukurov J.Z., and J.B.Kerimov. (1983). Medicinal plants of Azerbaijan, Maarif, Baku (in Russian)
3. Muravyova, D.A. (1991). Pharmacognosy, Medicina, Moscow (in Russian)
4. Khalmatov, H.H., Kharlamov I.A., and Z.I. Mavlankulova, (1998). Medicinal plants of Central Asia, Ibn Sina Press, Tashkent (in Russian)
5. Kapoor, L.D. (2001). Handbook of Ayurvedic Medicinal Plants, CRC Press
6. Daniel, M. (2006). Medicinal Plants:Chemistry and Properties, Science Publishers, Enfield, NH, USA
7. Shahverdi, A. R., H.R.Monsef-Esfahani, B.Nikavar, L. Bitarafan, S. Khodaee, N.Khoshakhlagh (2005). Antimicrobial activity and main chemical composition of two smoke condensates from Peganum harmala seeds. Zeitschrift für Naturforschung, 60(9-10): 707-710.
8. Alakbarli, F. (2006). Medical Manuscripts of Azerbaijan, Heydar Aliyev Foundation, Baku

9. Berrougui, H.; Martín-Cordero, C.; Khalil, A.; Hmamouchi, M.; Ettaib, A.; Marhuenda, E.; Herrera, M. D.(2006). Vasorelaxant effects of harmine and harmaline extracted from Peganum harmala L. seeds in isolated rat aorta. Pharmacological Research, 54, 150-157.
10. Jbilou, R.; Amri, H.; Bouayad, N.; Ghailani, N.; Ennabili, A.; Sayah, F.(2008). Insecticidal effects of extracts of seven plant species on larval development, alpha-amylase activity and offspring production of Tribolium castaneum (Herbst) (Insecta: Coleoptera: Tenebrionidae). Bioresour. Technology, 99, 959-964.
11. Agedilova, M. T.; Turmukhambetov, A. Z.,; Schultz, E. E.; Shakirov, M. M.; Adekenov, S. M. (2006). Components of the aerial part of Peganum harmala. Chemistry of Natural Compounds, 42, 226-227.
12. Somer E., (1992). The essential Guide to Vitamins and Minerals, NY: Harper Collins Publishers, New York
13. Bourke, C.A., M.J.Carrigan, R.J. Dixon (1990). Upper motor neurone effects in sheep of some beta‐carboline alkaloids identified in zygophyllaceous plants. Australian veterinary journal, 67(7): 248-251.
14. Herraiz T., González D., Ancin-Azpilicueta C., Arán V.J., Guillén H. (2010). β-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO). Food and Chemical Toxicology, 48 (3): 839-845.
15. Farzin, D., et al. (2011). Effects of harmane and other β-carbolines on apomorphine-induced licking behavior in rat. Pharmacology Biochemistry and Behavior, 98(2): 215-219.
16. Youdim, M. B. and M. Weinstock (2004). Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation. Neurotoxicology, 25(1): 243-250.
17. Herraiz, T. and C. Chaparro (2005). Human monoamine oxidase is inhibited by tobacco smoke: β-carboline alkaloids act as potent and reversible inhibitors. Biochemical and biophysical research communications, 326(2): 378-386.
18. Youdim, M. B., D, Edmondson, K.F. Tipton (2006). The therapeutic potential of monoamine oxidase inhibitors. Nature Reviews Neuroscience, 7 (4): 295-309.
19. Murray, M. (1996). Encyclopedia of Nutritional Supplements. Prima Publishing
20. Mamedov N., Aliyeva S., and T Musayeva, (1994). Syrian rue in traditional herbal medicine of Azerbaijan (independent study project), National Academy of Sciences, Institute of Botany, Baku (in Russian)
21. Tahraoui, A.; El-Hilaly, J.; Israili, Z. H.; Lyoussi, B. (2007). Ethnopharmacological survey of plants used in the traditional treatment of hypertension and diabetes in south-eastern Morocco (Errachidia province). J. Ethnopharmacol., 110, 105-117.
22. Farouk, L.; Laroubi, A.; Aboufatima, R.; Benharref, A.; Chait, A. (2008). Evaluation of the analgesic effect of alkaloid extract of Peganum harmala L.: possible mechanisms involved. J. Ethnopharmacol., 115, 449-454
23. Jahaniani, F.; Ebrahimi, S. A.; Rahbar-Roshandel, N.; Mahmoudian, M.(2005). Xanthomicrol is the main cytotoxic component of Dracocephalum kotschyii and a potential anti-cancer agent. Phytochemistry, 66, 1581-1592.
24. Baum, S. S., R.Hill, H. Rommelspacher (1996). Harman-induced changes of extracellular concentrations of neurotransmitters in the nucleus accumbens of rats. European journal of pharmacology, 314(1): 75-82.
25. Grella, B., M. Dukat, R. Younga, M. Teitlerb, K. Henrick-Davisb, C.B. Gauthierb, R.A. Glennon (1998). Investigation of hallucinogenic and related β-carbolines. Drug and Alcohol dependence, 50(2): 99-107.
26. Glennon, R. A., M. Dukat, B. Grella, Seoung-Soo Hong, L. Constantino, M. Teitler, C. Smith, C. Egan, K. Davis, M. Mattson (2000). Binding of β-carbolines and related agents at serotonin (5-HT 2 and 5-HT 1A), dopamine (D 2) and benzodiazepine receptors. Drug and Alcohol dependence, 60(2): 121-132.
27. Stephens, D., H.H. Schneider, W. Kehr, Jensen L.N., Petersen E., Honore T. (1987). Modulation of anxiety by β-carbolines and other benzodiazepine receptor ligands: relationship of pharmacological to biochemical measures of efficacy. Brain research bulletin, 19(3): 309-318.
28. Brush, D. E., S.B. Bird, E.W.Boyer (2004). Monoamine oxidase inhibitor poisoning resulting from Internet misinformation on illicit substances. Journal of Toxicology: Clinical Toxicology, 42(2): 191-195.